OptiBiotix Health (GB:OPTI) has released an update.
OptiBiotix Health plc, a developer of compounds for various health conditions, is set to engage with shareholders through a live presentation by CEO Stephen O’Hara on 20 May 2024. The session will cover the company’s commercial advancements, e-commerce growth, and product launches in the USA and Asia. Shareholders and potential investors are invited to register for the event to learn more about OptiBiotix’s strategic updates and pose questions.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
